Nachrichten zur AstraZeneca PLC Aktie

Donald Trump: AstraZeneca und USA einigen sich auf Vereinbarung zu Medikamentenpreisen

Donald Trump drängt Pharmakonzerne, ihre Preise zu reduzieren. Nun hat sich mit AstraZeneca ein zweites Unternehmen auf eine Vereinbarung eingelassen.…

Trump reaches deal with AstraZeneca to lower U.S. drug prices, MSNBC reports

Trump is set to announce the agreement with AstraZeneca on Friday, after striking a similar deal with Pfizer late last…

Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly

Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after…

AstraZeneca: 4,5 Mrd. USD-Produktionsoffensive in den USA, Onkologie-Pipeline, Preisdruck - was überwiegt?

Bad Marienberg (www.aktiencheck.de) - ???? Executive Summary: Produktionsoffensive in den USA, intakte Wachstumsnarrative, Kurs 148,15 EUR (-0,37 %)AstraZeneca hat in…

AstraZeneca to invest $4.5 billion in Virginia manufacturing facility By Investing.com

AstraZeneca to invest $4.5 billion in Virginia manufacturing facility…

AstraZeneca breaks ground at $4.5 billion Virginia plant as drugmakers court Trump

AstraZeneca broke ground on a new plant in Virginia on Thursday and said it would spend $4.5 billion on the…

AstraZeneca plans to increase investment and scope of its Virginia manufacturing facility to $4.5 billion, creating 3,600 new jobs

WILMINGTON, Del., October 09, 2025--AstraZeneca today announces that it will invest $4.5 billion in its new manufacturing facility in Virginia,…

AstraZenecas Baxdrostat Meets Goal in Resistant Hypertension Study

AZNs baxdrostat hit the main goal in the phase III Bax24 study, showing significant blood pressure reductions in patients with…

„Das schlechteste Land in Europa“ – Das Ende des britischen Pharma-Traums

Plötzlich blasen AstraZeneca, Merck und andere Konzerne große Investitionen in Großbritannien ab. Einst galt der Staat als attraktiver Standort für…

AstraZeneca’s baxdrostat hits key goal in major blood pressure trial

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) said its experimental drug baxdrostat met the main target in a late-stage study for patients with…

AstraZeneca’s experimental hypertension drug shows promising results By Investing.com

AstraZeneca’s experimental hypertension drug shows promising results…

AstraZeneca signs up to $555 million deal with US-based Algen to develop gene therapies

Algen Biotechnologies said on Monday it has agreed to grant AstraZeneca a license to develop gene therapies the U.S.-based biotech…

Astrazeneca (AZN) Rises Higher Than Market: Key Facts

Astrazeneca (AZN) closed at $85.31 in the latest trading session, marking a +1.98% move from the prior day.…

Silver Lake’s deal spree: bigger, bolder, better?

Plus, the cloistered district home to India’s richest and AstraZeneca hits the UK where it hurts…

AstraZeneca Stock Is Up 10% on Tariff News. But Is the Pharmaceutical Giant a Buy?

The uncertainty about U.S. pharmaceutical tariffs shouldnt be as worrisome for AstraZeneca now.…

AstraZeneca Stock Is Up 10% on Tariff News. But Is the Pharmaceutical Giant a Buy? @themotleyfool #stocks $AZN $PFE

The uncertainty about U.S. pharmaceutical tariffs shouldnt be as worrisome for AstraZeneca now.…

Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…

Insight: Trump administration targets deals in dozens of industries before midterms

Eli Lilly was asked to produce more insulin; Pfizer to produce more of its top-selling cancer drug Ibrance and its…

Two life science giants are joining forces in Gothenburg

American life science company Thermo Fisher Scientific, which is establishing a European bioanalytical laboratory in Gothenburg, has also announced a…

Thermo Fisher Scientific gibt Forschungskooperation mit AstraZeneca BioVentureHub bekannt

WILMINGTON, N.C.--(BUSINESS WIRE)--Der Geschäftsbereich PPD™ Clinical Research von Thermo Fisher Scientific, dem weltweit führenden Anbieter von wissenschaftlichen Dienstleistungen, hat heute…

Total Voting Rights

1 October 2025Transparency DirectiveVoting rights and capitalThe following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure…

AstraZeneca and other UK pharma boosted by Trumps first drug discount deal with Pfizer

Shares in the UKs biggest drug companies led the way on Wednesday, following news overnight that the US government had…

Analysis-AstraZenecas US listing may pull other firms from London in its wake

LONDON (Reuters) -AstraZeneca’s move to upgrade its listing in the U.S. risks pulling liquidity away from London’s stock market and…

AstraZeneca Aktie NYSE Listing 2025: Große Wende oder cleverer Schachzug?

Bad Marienberg (www.aktiencheck.de) - AstraZeneca schaltet direktes Listing in New York – bleibt aber im UKAstraZeneca vollzieht strategischen Börseschachzug …

AstraZenecas New York listing tweak dubbed a knock-back for London

Shares in AstraZeneca PLC (LSE:AZN) rose on Monday as it shared plans to directly list its shares on the New York Stock…

AstraZeneca: Ein defensiver Anker mit starken Produktportfolio

Trotz der zuletzt schwachen Entwicklung im Gesundheitssektor bleibt AstraZeneca (LSE: AZN) ein spannender Wert für langfristig orientierte Anleger. Die Pharmaindustrie…

AstraZeneca plant Direktlisting an der New Yorker Börse

Der britisch-schwedische Pharmakonzern AstraZeneca PLC (LSE: AZN) hat angekündigt, seine Stammaktien künftig direkt an der New York Stock Exchange (NYSE)…

AstraZeneca plans New York Stock Exchange listing but isn’t quitting London

FTSE 100’s second-biggest firm will also retain HQ in Cambridge and maintain its London listing…

AstraZeneca to list directly on NYSE while keeping U.K. listing; shares up By Investing.com

AstraZeneca to list directly on NYSE while keeping U.K. listing; shares up…

FTSE 100 Live: London stocks near all-time high as GSK and AstraZeneca rise

FTSE 100 up 62 points to 9,346 GSK rises as CEO change announced Gold miners lifted as precious metal prices…

AstraZeneca switches to direct US listing, keeps UK listing By Reuters

AstraZeneca switches to direct US listing, keeps UK listing…

AstraZeneca Boosts US Listing In Latest Pivot Away From UK

AstraZeneca Plc, the UK’s biggest drugmaker, plans to list regular shares on the New York Stock Exchange to attract more…

AstraZeneca to cut some direct-to-patient US drug prices after Trump demand

AstraZeneca said on Friday it will sell its diabetes and asthma drugs direct to cash-paying U.S. patients at a discount…

Astrazeneca (AZN) Declines More Than Market: Some Information for Investors

The latest trading day saw Astrazeneca (AZN) settling at $73.53, representing a -2.43% change from its previous close.…

AstraZeneca Stock Rises 15% YTD: Should You Buy, Sell or Hold?

AstraZeneca stock is up 15% so far in 2025 as blockbuster drugs and a robust oncology portfolio fuel growth despite…

AZN Gets CHMP Nod for Label Expansion of Koselugo & Tezspire

AstraZeneca wins CHMP backing for label expansions of Koselugo in adult NF1 PN patients and Tezspire in chronic rhinosinusitis with…

FTSE 100 gives up early gains as Kingfisher surges

The FTSE 100 gave up early gains on Tuesday as losses in heavyweights such as BAE Systems and AstraZeneca offset…

Astrazeneca (AZN) Stock Slides as Market Rises: Facts to Know Before You Trade

Astrazeneca (AZN) closed at $76.28 in the latest trading session, marking a -1.03% move from the prior day.…

PFE vs. AZN: Which Cancer-Focused Drug Giant Is the Better Pick?

AstraZeneca and Pfizer both boast strong oncology pipelines, but growth paths, dividends and challenges set them apart for investors.…

ANALYSE-FLASH: JPMorgan belässt Astrazeneca auf 'Overweight' - Ziel 14000 Pence

NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Astrazeneca mit einem…

Puma (PBYI) Q2 Revenue Rises 11%

Key PointsNon-GAAP EPS was $0.15, beating the non-GAAP estimate of $0.09 and turning positive on a GAAP basis from a…

Arcutis (ARQT) Q2 Revenue Soars 164%

Key PointsRevenue (GAAP) soared 164% year over year to $81.5 million, surpassing analyst estimates by $7.81 million (GAAP).Net loss per…

Proactive weekly health highlights: AstraZeneca, GSK, hVIVO, Avacta, and more

…

Total Voting Rights

1 August 2025 Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure…

Kimberly-Clark, Hims & Hers Health, CNH Industrial

U.S. stock index futures extended losses on Friday after a weaker-than-expected July jobs report elevated concerns about the health of…

Ionis (IONS) Q2 Revenue Soars 101%

Key PointsIonis Pharmaceuticals (NASDAQ:IONS) reported Q2 2025 GAAP revenue and non-GAAP earnings per share that exceeded analyst expectations by wide…

FIVE at FIVE: BAE, Taylor Wimpey, Arkle, Cornish Metal, AstraZeneca

Its that time again ... so, lets take a look at five pieces of content worth digging into deeper this…

Stocks Halt Rally as Bond Yields Fall Ahead of Fed Decision | The Close 7/29/2025

Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after…

US Expansion Not Driven By Tariffs: AstraZeneca CFO

Aradhana Sarin, AstraZeneca CFO, says the company is making a significant commitment to the U.S., explaining that the majority of…

AstraZenecas US Investment, Future of Psychedelic Therapy | Bloomberg Businessweek Daily 7/29/2025

On todays episode of Bloomberg Businessweek Daily with Tim Stenovec and Carol Massar, Pascal Soriot, Chief Executive Officer of AstraZeneca…